Post Prandial Glucose Control Proof-of-Principle

March 29, 2011 updated by: Abbott Nutrition
The purpose of this study is to compare the postprandial glycemic response of subjects with type 2 diabetes when consuming a meal along with beverages containing various combinations of nutritional ingredients and fibers versus control beverage.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45249
        • Radiant Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. type 2 diabetes
  2. between 21 and 75 years of age
  3. male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile
  4. BMI is > 18.5 kg/m2 and <35 kg/m2
  5. HbA1c < 9.0%

Exclusion Criteria:

  1. Subject uses exogenous insulin, exenatide, or sitagliptin phosphate
  2. type 1 diabetes.
  3. history of diabetic ketoacidosis.
  4. current infection
  5. active malignancy
  6. has had a significant cardiovascular event or history of congestive heart failure.
  7. end-stage organ failure or post organ transplant.
  8. history of renal disease.
  9. hepatic disease.
  10. history of gastrointestinal disorders
  11. chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  12. taking any herbals, dietary supplements, or medications, other than oral hypoglycemic medications
  13. clotting or bleeding disorders.
  14. allergic or intolerant to any ingredient found in the study products.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Nutritional ingredient
Dissolve in water and consume with meal
Dissolve in water and consume with meals
PLACEBO_COMPARATOR: Carbohydrate
dissolve in water and consume with meal
dissolve in water and consume with meal
EXPERIMENTAL: #1 Nutrtitional ingredient + Fiber
Dissolve in water and consume with meal
Dissolve in water and consume with meal
EXPERIMENTAL: #2 Nutritional ingredient + Fiber
Dissolve in water and consume with meal
Dissolve in water and consume with meal
EXPERIMENTAL: #3 Nutritional ingredient + Fiber
Dissolve in water and consume with meal
Dissolve in water and consume with meal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Positive AUC from 0 to 240 minutes for plasma glucose.
Time Frame: 0 to 240 minutes
0 to 240 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Plasma glucose concentrations
Time Frame: 0 to 240 minutes
0 to 240 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (ACTUAL)

September 1, 2010

Study Completion (ACTUAL)

September 1, 2010

Study Registration Dates

First Submitted

March 28, 2011

First Submitted That Met QC Criteria

March 29, 2011

First Posted (ESTIMATE)

March 30, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

March 30, 2011

Last Update Submitted That Met QC Criteria

March 29, 2011

Last Verified

March 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Nutritional ingredient

3
Subscribe